The ASCO Annual Meeting is one of the largest medical congresses in the world, with around 25,000 physicians expected to attend. This year is the 50thanniversary of the founding of this meeting, which allows us to reflect on how much progress has been made in the treatment of cancer while also looking forward to the future.
Roche will be presenting data at this meeting on 27 different approved and investigational medicines, covering 19 different tumour types, demonstrating our continuing commitment to improve outcomes for people with cancer.
Alongside our data, Roche looks forward to engaging with healthcare professionals and patient groups on many topical issues around cancer care. Our position on some of these topics can be found below.